Cite

HARVARD Citation

    Lin, J. et al. (n.d.). 632 HPN601 is a protease-activated EpCAM-targeting T cell engager with an improved safety profile for the treatment of solid tumors. Journal for immunotherapy of cancer. p. A668. [Online]. 
  
Back to record